The FlexTouch is the latest prefilled insulin device from Danish global healthcare company Novo Nordisk. The new device, used by individuals with diabetes, provides a new insulin delivery experience and is a followup to the highly successful and popular FlexPen, which dominated the industry for the past decade.
The FlexTouch has a bevy of helpful features that reflect the technological innovations that have emerged in the last ten years. Voted easiest to use by medical professionals and patients, the FlexTouch is designed to be user-friendly and is advertised as requiring five times less pressure to inject than other comparative devices. Additionally, the FlexTouch boasts the inclusion of an end-of-dose "click," which makes confidence in the process easier.
The FlexTouch is Novo Nordisk's Followup to the Venerable FlexPen
Rebecca Byers — June 24, 2015 — Tech
References: novonordisk & healthline